journal article·2018-11-17Open access

In vitro anti-inflammatory activity of spherical silver nanoparticles and monodisperse hexagonal gold nanoparticles by fruit extract of Prunus serrulata : a green synthetic approach

Priyanka Singh, Sungeun Ahn, Jong-Pyo Kang, Soshnikova Veronika, Yue Huo, Hina Singh, Mohan Chokkaligam, Mohamed El-Agamy Farh, Verónica Castro Aceituno, Yeon Ju Kim, Deok-Chun Yang

Abstract

Recently, green metal nanoparticles have received global attention owing to their economical synthesis, biocompatible nature, widespread biomedical and environmental applications. Current study demonstrates a sustainable approach for the green synthesis of silver nanoparticles (P-AgNPs) and gold nanoparticles (P-AuNPs) from P. serrulata fresh fruit extract. The silver and gold nanoparticles were synthesized in a very rapid, efficient and facile manner, within 50 min and 30 s at 80 °C, respectively. The nanoparticles were characterized by using visual observation, UV-Vis, FE-TEM, EDX, elemental mapping, FT-IR, XRD and DLS, which confirmed the formation of monodispersed, crystalline and stable nanoparticles. Further, we explored these nanoparticles for anti-inflammatory activity through inhibition of downstream NF-κB activation in macrophages (RAW264.7). We demonstrated that the nanoparticles reduced expression of inflammatory mediators such as nitric oxide (NO), prostaglandin E2 (PEG2), inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) was attenuated in lipopolysaccharide (LPS)-induced RAW264.7 cells. Furthermore, nanoparticles significantly suppressed LPS-induced activation of NF-κB signalling pathway via p38 MAPK in RAW 264.7 cells. To the best of our knowledge, this is the first report on the efficient green synthesis of P-AgNPs and P-AuNPs using P. serrulata fresh fruit extract and its in vitro anti-inflammatory effects. Collectively, our results suggest that P. serrulata fresh fruit extract is a green resource for the eco-friendly synthesis of P-AgNPs and P-AuNPs, which further can be utilized as a novel therapeutic agent for prevention and cure of inflammation due to their biocompatible nature.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Medicinal Plants and Neuroprotection · Vitamin C and Antioxidants Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Oriental Medicine Biotechnology, Ginseng Bank, College of Life Science, Kyung Hee University

Graduate School of Biotechnology, College of Life Science, Kyung Hee University

Funding

Rural Development Administration

References (42)

Show source-provided references
1. 10.3109/21691401.2015.111541010.3109/21691401.2015.1115410 ↗
2. 10.1155/2015/23474110.1155/2015/234741 ↗
3. 10.2147/IJN.S7231310.2147/IJN.S72313 ↗
4. 10.1016/j.tibtech.2016.02.00610.1016/j.tibtech.2016.02.006 ↗
5. 10.3109/21691401.2015.101180910.3109/21691401.2015.1011809 ↗
6. 10.3109/21691401.2015.100851410.3109/21691401.2015.1008514 ↗
7. 10.3109/21691401.2015.104164010.3109/21691401.2015.1041640 ↗
8. 10.1016/j.enzmictec.2016.02.00510.1016/j.enzmictec.2016.02.005 ↗
9. 10.3109/21691401.2015.106493710.3109/21691401.2015.1064937 ↗
10. 10.3109/21691401.2015.111541010.3109/21691401.2015.1115410 ↗
11. 10.3109/21691401.2016.116371510.3109/21691401.2016.1163715 ↗
12. 10.3109/21691401.2015.106879210.3109/21691401.2015.1068792 ↗
13. 10.1016/j.enzmictec.2016.08.01810.1016/j.enzmictec.2016.08.018 ↗
14. 10.5487/TR.2016.32.2.09510.5487/TR.2016.32.2.095 ↗
15. 10.2147/IJN.S10854910.2147/IJN.S108549 ↗
16. 10.32607/20758251-2014-6-1-35-4410.32607/20758251-2014-6-1-35-44 ↗
17. 10.1186/s11671-016-1257-410.1186/s11671-016-1257-4 ↗
18. 10.1016/j.biopha.2016.09.01610.1016/j.biopha.2016.09.016 ↗
19. 10.1016/j.drudis.2014.11.01410.1016/j.drudis.2014.11.014 ↗
20. 10.2147/IJN.S5501510.2147/IJN.S55015 ↗
21. 10.1080/21691401.2016.122866110.1080/21691401.2016.1228661 ↗
22. 10.32607/20758251-2011-3-2-34-5510.32607/20758251-2011-3-2-34-55 ↗
23. 10.1517/1742524100377701010.1517/17425241003777010 ↗
24. 10.2174/09298671180341438610.2174/092986711803414386 ↗
25. 10.1142/S0192415X1000836610.1142/S0192415X10008366 ↗
26. 10.1007/s12272-001-1162-010.1007/s12272-001-1162-0 ↗
27. 10.2174/13895570677793493710.2174/138955706777934937 ↗
28. 10.1016/j.fct.2010.07.04810.1016/j.fct.2010.07.048 ↗
29. 10.5142/jgr.2013.37.5410.5142/jgr.2013.37.54 ↗
30. 10.1023/B:MCBI.0000044364.73144.fe10.1023/B:MCBI.0000044364.73144.fe ↗
31. 10.1039/c1gc15386b10.1039/c1gc15386b ↗
32. 10.1038/aps.2013.2410.1038/aps.2013.24 ↗
33. 10.1016/j.ejphar.2008.01.03210.1016/j.ejphar.2008.01.032 ↗
34. 10.1016/j.bbrc.2007.05.04210.1016/j.bbrc.2007.05.042 ↗
35. 10.1007/s11626-015-9983-y10.1007/s11626-015-9983-y ↗
36. 10.1097/00024382-200208000-0000110.1097/00024382-200208000-00001 ↗
37. Wang T, Wu F, Jin Z, et al. Plumbagin inhibits LPS-induced inflammation through the inactivation of the nuclear factor-kappa B and mitogen activated protein kinase signaling pathways in RAW 264.7 cells. Food Chem Toxicol. 2014;11:177–183.10.1016/j.fct.2013.11.027 ↗
38. 10.2147/IJN.S9718110.2147/IJN.S97181 ↗
39. 10.1371/journal.pone.015866210.1371/journal.pone.0158662 ↗
40. 10.1016/j.intimp.2013.11.02210.1016/j.intimp.2013.11.022 ↗
41. 10.1016/j.intimp.2012.05.00510.1016/j.intimp.2012.05.005 ↗
42. 10.1016/j.phymed.2010.11.01010.1016/j.phymed.2010.11.010 ↗